VivePeptides logo

Research Use Only

Peptides for Inflammation

Peptides investigated in the context of cytokine signaling, immunomodulation, and inflammatory resolution.

Peptides for Inflammation are research compounds studied for their roles in modulating inflammatory signaling pathways, immune cell activity, and tissue-level regulatory processes. This category encompasses cytoprotective growth factor modulators, actin-sequestering tissue-remodeling peptides, thymic immune-signaling peptides, cathelicidin-derived innate immune modulators, and erythropoietin-derived repair-receptor ligands, all investigated in preclinical models and supplied for laboratory research use only.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

BPC-157 research peptide vial

BPC-157

$75.00View
TB-500 research peptide vial

TB-500

$89.00View
Thymosin Alpha 1 research peptide vial

Thymosin Alpha 1

$95.00View
LL-37 research peptide vial

LL-37

$109.00View
ARA-290 research peptide vial

ARA-290

$75.00View

Research Overview

Inflammation Research Peptides: What This Category Covers

The peptides for inflammation research category encompasses compounds that interact with distinct molecular regulators of acute and chronic inflammatory response. Inflammation research is an active area of preclinical investigation because inflammatory signaling underpins a broad range of biological models, from tissue injury to immune dysregulation.

The mechanism classes represented in this collection include cytoprotective growth factor modulators (BPC-157), actin-sequestering tissue-remodeling peptides (TB-500), thymic immune-signaling peptides (Thymosin Alpha 1), cathelicidin-derived innate immune modulators (LL-37), and erythropoietin-derived innate repair receptor ligands (ARA-290). Each compound targets a different node of the inflammatory network, allowing researchers to design studies that interrogate specific pathways rather than relying on broad, non-selective suppression.

VivePeptides supplies these anti inflammatory peptides at research grade, with certificates of analysis and purity documentation supporting reproducible experimental protocols.

Five Distinct Mechanism Classes

This collection spans five mechanistically separate compound classes, from actin-sequestration to innate repair receptor activation, enabling researchers to interrogate specific nodes of inflammatory signaling rather than relying on a single pathway approach.

Purity Documentation for Reproducible Research

Each inflammation peptide supplied by VivePeptides includes a certificate of analysis confirming purity by HPLC, providing the analytical documentation required for reproducible preclinical experimental protocols.

Compound Selection by Research Model

Researchers align compound selection with the specific inflammatory pathway and model system under investigation, whether the focus is innate immune signaling, adaptive immune compartment regulation, or tissue-level inflammatory resolution in vitro or in vivo.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
BPC-157Cytoprotective growth factor modulatorGrowth factor receptor and vascular signalingStable synthetic gastric pentadecapeptide
TB-500Actin-sequestering tissue remodeling peptideCellular migration and inflammatory resolutionSynthetic Thymosin Beta-4 analogue
Thymosin Alpha 1Thymic immune-signaling peptideToll-like receptor pathway and T-cell regulationEndogenous thymic peptide origin
LL-37Cathelicidin-derived innate immune modulatorAntimicrobial and pattern-recognition receptor signalingDual antimicrobial and immune-signaling roles
ARA-290Innate repair receptor ligandNon-erythropoietic receptor engagementSelective IRR activation, distinct from EPO receptor

Mechanism & Research Context

Mechanism Classes and Preclinical Research Context for Inflammation Peptides

What distinguishes the anti inflammatory peptides in this collection is the diversity of upstream targets each compound engages within the inflammatory cascade. BPC-157 has been investigated in preclinical models for its influence on growth factor receptor signaling and vascular regulatory pathways. TB-500 research examines actin-sequestration dynamics and their downstream effects on cellular migration and inflammatory resolution.

Thymosin Alpha 1 is studied for its role in toll-like receptor pathway modulation and T-cell compartment regulation. LL-37, a cathelicidin-derived peptide, is investigated for its dual function as an antimicrobial agent and an innate immune signaling molecule that interacts with pattern-recognition receptors. ARA-290 research focuses on selective engagement of the innate repair receptor, a pathway distinct from classical erythropoietin receptor activation.

Researchers selecting among these compounds typically align compound choice with the inflammatory node and cell type most relevant to their in vitro or in vivo model system.

Research FAQ

Frequently asked questions

What are peptides for inflammation used for in research?

Peptides for inflammation are research compounds studied in preclinical models to investigate how specific molecular pathways regulate acute and chronic inflammatory responses. Each compound in this category targets a distinct mechanistic node, such as growth factor signaling, actin-sequestration, or toll-like receptor modulation. These peptides are supplied for laboratory research use only and are not intended for human or animal administration.

What is the difference between BPC-157 and TB-500 in inflammation research?

BPC-157 and TB-500 represent distinct mechanism classes, with BPC-157 studied as a cytoprotective growth factor modulator and TB-500 investigated as an actin-sequestering tissue-remodeling peptide. The preclinical literature on BPC-157 centers on vascular regulatory and growth factor receptor signaling, while TB-500 research examines cellular migration dynamics and inflammatory resolution. Researchers typically select between them based on which pathway and cell type is most relevant to the experimental model.

How does Thymosin Alpha 1 relate to inflammation peptide research?

Thymosin Alpha 1 is a thymic peptide studied in the preclinical literature for its role in toll-like receptor pathway modulation and T-cell compartment regulation, both of which are central to adaptive immune responses implicated in inflammatory states. Research has examined its effects on immune signaling cascades in models of immune dysregulation. It is available from VivePeptides for laboratory research use only.

What makes LL-37 relevant to the study of inflammation?

LL-37 is a cathelicidin-derived peptide investigated for a dual role as both an antimicrobial agent and an innate immune signaling molecule that interacts with pattern-recognition receptors. This dual function makes LL-37 of particular interest to researchers studying the intersection of innate immunity and inflammatory signaling cascades. It is studied in preclinical in vitro and in vivo models and is supplied for research use only.

What is ARA-290 and how is it used in inflammation research models?

ARA-290 is an erythropoietin-derived peptide studied for selective engagement of the innate repair receptor, a pathway distinct from classical erythropoietin receptor activation that has been investigated in preclinical models of neuropathic and tissue-level inflammation. Research has examined its influence on inflammatory signaling through this non-erythropoietic receptor mechanism. ARA-290 is available from VivePeptides for laboratory research use only.

How do researchers choose between the inflammation peptides in this collection?

Researchers select among inflammation peptides by aligning each compound's mechanism class with the specific inflammatory pathway, cell type, and model system under investigation. Studies targeting innate immune signaling may prioritize LL-37 or ARA-290, while models examining tissue-level inflammatory resolution may be better suited to BPC-157 or TB-500. Research questions involving adaptive immune compartment modulation typically point toward Thymosin Alpha 1 as the most mechanistically relevant candidate.

Related Research Collections

Continue exploring

Peptides for RecoveryHealing PeptidesPeptides for Joint RepairPeptides for Gut Health

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.